EN
HI
Rekvina Laboratories Chart
Rekvina Laboratories Share Key Metrics
Volume
22967.00
Market Cap
24.51 CR
LTQ@LTP
947@41.47
ATP
41.16
Var Margin
100 %
Circuit Range
39.85-41.47
Delivery %
100 %
Value
9.45 L
ASM/GSM
No
Market Lot
1
Summary
At 15 Apr, 2026 | 15:15, Rekvina Laboratories share price stands at ₹41.47, showing a 0.81% 1.99 for the day. The stock’s intraday movement has stayed between ₹39.85 and ₹41.47, while on a 52-week basis it has fluctuated from ₹6.75 to ₹41.47.
In terms of trading activity, Rekvina Laboratories has recorded a volume of 22967 shares, with a market capitalisation of ₹6028000. The stock’s Average Traded Price (ATP) stands at ₹4116, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 947,4147. The stock operates within a circuit range of ₹39.85-41.47, with a Value of ₹9.45 L. The Delivery Percentage for the day is 100%. Additionally, Rekvina Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Rekvina Laboratories Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
40.33
Sector P/B
1.92
Sec. Div. Yield
82.31
Rekvina Laboratories Resistance and Support
Pivot 40.66
Resistance
First Resistance
40.66
Second Resistance
40.66
Third Resistance
40.66
Support
First Support
40.66
Second Support
40.66
Third Support
40.66
Rekvina Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-03-16 | Preferential Issue of shares |
| 2026-02-06 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-01-20 | Quarterly Results |
Rekvina Laboratories News
Rekvina Laboratories Ltd - 526075 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Rekvina Laboratories shareholders have approved all proposed resolutions at the Extra-Ordinary General Meeting held on April 10, 2026. Key approvals include an increase in authorized share capital and two preferential issues of equity shares, enhancing the company's financial flexibility and capital structure.
Apr 10 2026 17:04:00
Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Open Offer - Updates
Acquirers for Rekvina Laboratories Limited announced an open offer to acquire up to 26% of its expanded share capital at ₹10 per share, aggregating ₹2.89 crore. The offer's tendering period is from May 14 to May 27, 2026, and is triggered by Rekvina's prior acquisition of Radiant Parenterals Limited via a share swap.
Apr 02 2026 18:04:00
Read More
About Rekvina Laboratories
NSE : 0
BSE : 526075
ISIN : INE092O01028
Rekvina Laboratories Management
| Name | Position |
|---|---|
| Mr. Amit Mukesh Shah | Managing Director |
| Mrs. Iiaben Pathak | Non Exe.Non Ind.Director |
Rekvina Laboratories Similar Stocks
Rekvina Laboratories FAQs
The Buying Price of Rekvina Laboratories share is 41.47 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Rekvina Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Rekvina Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Rekvina Laboratories shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Rekvina Laboratories shares is 0. Useful to assess the stock's value relative to its book value.
To assess Rekvina Laboratories’s valuation compare Sector P/E, P/B which are 40.33 & 1.92 with sector averages, along with growth rates and financial metrics.
The Market Cap of Rekvina Laboratories is 24.51 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Rekvina Laboratories share price is 41.47 & 6.75. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Rekvina Laboratories belongs to the Miscellaneous sector.
